LifeVantage to Announce Third Quarter Fiscal Year 2023 Results on May 4, 2023
LifeVantage Corporation (Nasdaq: LFVN) announced it will disclose its financial results for the third quarter, ending March 31, 2023, on May 4, 2023, post-market close. A conference call for investors is scheduled for 2:30 p.m. MT (4:30 p.m. ET) on the same day. Interested participants can call (877) 704-4453 for U.S. access or (201) 389-0920 for international callers. A replay will be available two hours after the call until May 11, 2023. The company specializes in nutrigenomics and offers a variety of dietary supplements and wellness products, including the Protandim family and Petandim for pets. For further details, visit their Investor Relations web page.
- Scheduled financial results release, indicating transparency.
- Upcoming conference call, allowing direct investor engagement.
- None.
SALT LAKE CITY, April 20, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its third quarter ended March 31, 2023, after the stock market closes on Thursday, May 4, 2023. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, May 11, 2023, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13737266, or (412) 317-6671 from international locations, and entering confirmation code 13737266.
There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1605540&tp_key=203140be48. The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath & body, and targeted relief products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+™, ProBio™, IC Bright®, and Daily Wellness™ dietary supplements, the TrueScience® line of skin, hair, bath & body, and targeted relief products. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio® its nootropic energy drink mixes, and PhysIQ™, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
When will LifeVantage Corporation announce its financial results for Q3 2023?
What time is the LifeVantage investor conference call?
How can I listen to the LifeVantage financial results conference call?
Is there a replay available for the LifeVantage conference call?